Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 81
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 68
Drug Discovery 54
Cardiovascular Drugs 46
Biopharmaceuticals 37
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biotechnology 33
Genomics 28
Clinical Trials 22
Central Nervous System Drugs 19
Pharmaceuticals 19
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Infectious Diseases Drugs 18
Allergy and Immunology 17
Drugs by Therapeutic Area 16
Respiratory Drugs 15
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Gastrointestinal Drugs 11
Dermatology 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Biosimilars and Biosuperiors 7
Pharmaceutical Manufacturing 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Asthma Drugs 6
Therapeutic Area 5
Drug Delivery 5
Liver and Kidney Disorders Drugs 5
Gastroenterology 5
Company Reports 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Cough and Cold Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Anti-Obesity Drugs 2
Cardiology 2
Neurology 1
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

682 Results (Page 15 of 35)
- Relevance
  Sort by

ADC Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Stage of Development, Process Component, Target Indication, Antibody Generation, Antibody Origin, Antibody Isotype, Type of Payload, Type of Linker and Key Geographical Regions

 Report
November 2024
510 Pages
Global

From

€4279EUR$4,799USD£3,713GBP

Collaboration Deals in Pharmaceuticals 2020-2025

 Report
September 2025
950 Pages
Global

From

€4454EUR$4,995USD£3,865GBP

Metastatic Prostate Cancer- Pipeline Insight, 2025

 Clinical Trials
April 2025
180 Pages
Global

From

€2675EUR$3,000USD£2,321GBP

Mitoxantrone Hydrochloride Market - Global Forecast to 2030

 Report
August 2025
187 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Aplastic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
70 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Basal Cell Carcinoma Treatment Market - Global Forecast 2025-2032

 Report
October 2025
196 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

United States Ovarian Cancer Therapeutics Market, Competition, Forecast & Opportunities, 2028

 Report
October 2023
72 Pages
United States

From

€3121EUR$3,500USD£2,708GBP

Rare Autoinflammatory Diseases Drug Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

CD19 Target Drug Market - Global Forecast 2025-2030

 Report
August 2025
198 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Single-target Anti-VEGF Drugs Market - Global Forecast 2025-2030

 Report
August 2025
183 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3566EUR$3,999USD£3,094GBP

Age Related Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

 Report
July 2023
808 Pages
Global

From

€2229EUR$2,500USD£1,934GBP

Wet (Neovascular/Exudative) Macular Degeneration Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

 Report
July 2023
457 Pages
Global

From

€2229EUR$2,500USD£1,934GBP

Prostate Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4003EUR$4,490USD£3,474GBP

Allergy Drugs Market - Global Forecast 2025-2032

 Report
October 2025
181 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Chylomicronemia Syndrome Market - Global Forecast 2025-2030

 Report
August 2025
180 Pages
Global

From

€3161EUR$3,545USD£2,743GBP

€3512EUR$3,939USD£3,048GBP

Gastroenteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
July 2022
64 Pages
Global

From

€1783EUR$2,000USD£1,548GBP

Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

 Report
June 2023
280 Pages
Global

From

€2229EUR$2,500USD£1,934GBP

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
589 Pages
Global

From

€2229EUR$2,500USD£1,934GBP

North America Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

 Report
November 2022
74 Pages
North America

From

€1337EUR$1,500USD£1,161GBP

682 Results (Page 15 of 35)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.